Individuals were treated according to the group to which their practice was allocated: routine care according to national guidelines [14] (n = 23) or intensive multifactorial treatment (n = 26).
Individuals were diagnosed with diabetes according to 1999 WHO criteria and were subsequently managed according to the treatment regimen to which their practice was allocated: routine care or intensive treatment.
This primary comparison failed to reach significance, but by one year follow-up, patients allocated booklet self management (with or without telephone support) clearly improved relative to those allocated routine care, by reporting greater subjective improvement, fewer symptoms related to dizziness, and a reduced handicap related to dizziness.
For a cost ratio of 9 1 and a budget increase of 200 %, approximately 39%% of testing resources should be allocated to routine testing in acute care and the balance to routine testing in high prevalence settings.
If the multiplier δ v is increased from its base value of 0.04 to 0.30 and δ d is increased from its base value of 0.32 to 1.00, then approximately 80%% of resources should be allocated to routine testing in high prevalence settings and the remaining resources to routine testing in acute care.
When the cost ratio of a targeted test to a routine test increases above a threshold, which is approximately 1.68 for five-year incidence and 1.66 for ten-year incidence, then the optimal allocation of testing resources changes abruptly to all resources allocated to routine testing.
For example, with a 9 1 cost ratio and a 200 % increase in budget, five-year cumulative incidence is minimized at 44%% of resources allocated to routine testing in high prevalence settings for MSM, 22 % of resources allocated to routine testing in high prevalence settings for IDU-FSW, and the balance of resources allocated to routine testing in acute care.
Intention-to-treat and observed-cases analysis showed that patients in the EBI group gained significantly less weight than those allocated to routine care at intervention completion (3-month follow-up) with treatment effects maintained over 3 months.
Females, given that they were not allocated to routine tasks during the expansionary period, are not affected as much by these changes, probably due to the fact that they were already more specialized in jobs with high service content.
For no budget increase, all resources should be allocated to routine testing of MSM in high prevalence settings.
